Suven Pharmaceuticals (NSE:SUVENPHAR) YoY EPS Growth : 2.88% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Suven Pharmaceuticals's YoY EPS Growth for the quarter that ended in Sep. 2024 was 2.88%.

Suven Pharmaceuticals's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ₹3.21.

Suven Pharmaceuticals YoY EPS Growth Historical Data

The historical data trend for Suven Pharmaceuticals's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Pharmaceuticals YoY EPS Growth Chart

Suven Pharmaceuticals Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EPS Growth

Get a 7-Day Free Trial

190.01

14.30

25.30

-9.37

-26.98

Suven Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EPS Growth	Get a 7-Day Free Trial															10.25	-56.50	-56.88	-49.58	2.88

Suven Pharmaceuticals YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Suven Pharmaceuticals's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (A: Mar. 2024 )
=	(Earnings per Share (Diluted) (A: Mar. 2024 )	-	Earnings per Share (Diluted) (A: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (A: Mar. 2023 ) \|
=	(11.8	-	16.16)	/	\| 16.16 \|
=	-26.98 %

Suven Pharmaceuticals's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EPS Growth (Q: Sep. 2024 )
=	(Earnings per Share (Diluted) (Q: Sep. 2024 )	-	Earnings per Share (Diluted) (Q: Sep. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Sep. 2023 )) \|
=	(3.21	-	3.12)	/	\| 3.12 \|
=	2.88 %

Suven Pharmaceuticals YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Suven Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (NSE:SUVENPHAR) » Definitions » YoY EPS Growth

Traded in Other Exchanges

543064:India

Address

No. 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad, TG, IND, 500081

Website

https://www.suvenpharm.com

Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.

Suven Pharmaceuticals Headlines

No Headlines